BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28606014)

  • 1. TLR2-stimulating contaminants in glycoconjugate fractions prepared from Bacteroides fragilis.
    Hashimoto M; Waki J; Nakayama-Imaohji H; Ozono M; Hashiguchi S; Kuwahara T
    Innate Immun; 2017 Jul; 23(5):449-458. PubMed ID: 28606014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a TLR2-stimulating lipoprotein in Bacteroides fragilis JCM 11019 (NCTC 9343).
    Hashimoto M; Eguchi H; Tawaratsumida K; Kirikae T; Suda Y
    Innate Immun; 2013; 19(2):132-9. PubMed ID: 22890547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.
    Mancuso G; Midiri A; Biondo C; Beninati C; Gambuzza M; Macrì D; Bellantoni A; Weintraub A; Espevik T; Teti G
    Infect Immun; 2005 Sep; 73(9):5620-7. PubMed ID: 16113279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for TLR1, TLR2 and NOD2 in cytokine induction by Bacteroides fragilis.
    Stappers MH; Janssen NA; Oosting M; Plantinga TS; Arvis P; Mouton JW; Joosten LA; Netea MG; Gyssens IC
    Cytokine; 2012 Dec; 60(3):861-9. PubMed ID: 22998942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1β-induced inflammation in human fetal enterocytes via toll receptors 2 and 4.
    Jiang F; Meng D; Weng M; Zhu W; Wu W; Kasper D; Walker WA
    PLoS One; 2017; 12(3):e0172738. PubMed ID: 28278201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilis.
    Otto BR; Verweij WR; Sparrius M; Verweij-van Vught AM; Nord CE; MacLaren DM
    Infect Immun; 1991 Sep; 59(9):2999-3003. PubMed ID: 1879923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter orientation of the immunomodulatory
    Blandford LE; Johnston EL; Sanderson JD; Wade WG; Lax AJ
    Gut Microbes; 2019; 10(5):569-577. PubMed ID: 30732524
    [No Abstract]   [Full Text] [Related]  

  • 8. The interaction of Bacteroides fragilis with components of the human fibrinolytic system.
    Ferreira Ede O; de Carvalho JB; Peixoto RJ; Lobo LA; Zingalli RB; Smith CJ; Rocha ER; Domingues RM
    FEMS Immunol Med Microbiol; 2009 Jun; 56(1):48-55. PubMed ID: 19260960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bacteroides fragilis cell envelope: quarterback, linebacker, coach-or all three?
    Pumbwe L; Skilbeck CA; Wexler HM
    Anaerobe; 2006; 12(5-6):211-20. PubMed ID: 17045496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteroides fragilis signals through Toll-like receptor (TLR) 2 and not through TLR4.
    Alhawi M; Stewart J; Erridge C; Patrick S; Poxton IR
    J Med Microbiol; 2009 Aug; 58(Pt 8):1015-1022. PubMed ID: 19528164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pbp, a cell-surface exposed plasminogen binding protein of Bacteroides fragilis.
    Sijbrandi R; Stork M; Luirink J; Otto BR
    Microbes Infect; 2008 Apr; 10(5):514-21. PubMed ID: 18403231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.
    Surana NK; Kasper DL
    Immunol Rev; 2012 Jan; 245(1):13-26. PubMed ID: 22168411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of Toll-like receptor 2 in Bacteroides fragilis-mediated immune responses in murine peritoneal mesothelial cells.
    Kim TH; Lee KB; Kang MJ; Park JH
    Microbiol Immunol; 2012 Nov; 56(11):782-8. PubMed ID: 22938101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal model system for studying virulence of and host response to Bacteroides fragilis.
    Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bacteroides fragilis surface glycoprotein mediates the interaction between the bacterium and the extracellular matrix component laminin-1.
    de O Ferreira E; Araújo Lobo L; Barreiros Petrópolis D; dos S Avelar KE; Ferreira MC; e Silva Filho FC; Domingues RM
    Res Microbiol; 2006 Dec; 157(10):960-6. PubMed ID: 17125972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of intestinal and extra-intestinal strains of enterotoxigenic Bacteroides fragilis by the HT-29 cytotoxicity assay.
    Pantosti A; Cerquetti M; Colangeli R; D'Ambrosio F
    J Med Microbiol; 1994 Sep; 41(3):191-6. PubMed ID: 8064839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL
    J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The humoral antibody response to Bacteroides fragilis infections in humans.
    Lindberg AA; Weintraub A; Nord CE
    Scand J Infect Dis Suppl; 1979; (19):46-51. PubMed ID: 288165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orientations of the Bacteroides fragilis capsular polysaccharide biosynthesis locus promoters during symbiosis and infection.
    Troy EB; Carey VJ; Kasper DL; Comstock LE
    J Bacteriol; 2010 Nov; 192(21):5832-6. PubMed ID: 20729352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.